Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review – (Eye 31, 273 (February 2017))
Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review Eye 31, 273 (February 2017). doi:10.1038/eye.2016.286 Authors: N Brito-García, T del Pino-Sedeño, M M Trujillo-Martín, R M Coco, E Rodríguez de la Rúa, I del Cura-González & P Serrano-Aguilar
Evolution of the circuitry for conscious color vision in primates – (Eye 31, 286 (February 2017))
Evolution of the circuitry for conscious color vision in primates Eye 31, 286 (February 2017). doi:10.1038/eye.2016.257 Authors: J Neitz & M Neitz
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on – (Eye 31, 301 (February 2017))
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on Eye 31, 301 (February 2017). doi:10.1038/eye.2016.284 Author: J K Dart
Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors – (Eye 31, 333 (February 2017))
Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors Eye 31, 333 (February 2017). doi:10.1038/eye.2016.294 Authors: A N Warwick, A P Brooks, C Osmond & R Krishnan
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option – (Eye 31, 342 (February 2017))
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option Eye 31, 342 (February 2017). doi:10.1038/eye.2016.238 Authors: D Călugăru & M Călugăru